Introduction: breast cancer (BC) is the most common tumor and the leading cause of cancer-related death among the female populationworldwide. Polymorphisms genetics of ABCB1 gene contributed to breast cancer susceptibility and interindividual differences inchemotherapy response. Objectives: to evaluate the association between the ABCB1 C3435T gene polymorphism (SNPs) with theresponse to neoadjuvant chemotherapy in women with breast cancer. Methodology: this study included 32 female patients whoreceived neoadjuvant chemotherapy. The polymorphisms were genotyped through real-time allele-specific polymerase chain reaction(PCR). The statistical analysis was performed using the Fisher’s exact test or Pearson’s chi-square test in the Statistical Package forSocial Sciences (SPSS) version 20.0 software. Results: the genotypes found for the C3435T polymorphism were in Hardy-Weinbergequilibrium and their genotypic distributions were CC= 10 (31.1%), CT= 14 (43.8%), and TT= 08 (25.0%) with χ2: 0.86 and p-value >0.05. Allele frequencies were C = 0.54 and T = 0.46. There were no significant statistical differences between genotypes considering theresponse to neoadjuvant chemotherapy and immunohistochemistry; the presence of the T allele was associated with worsen axillarystatus response to neoadjuvant chemotherapy. Conclusion: no definite association between the presence of C3435T polymorphismand the response to neoadjuvant chemotherapy was observed. Further studies in Brazil involving larger samples will contribute tovalidating the results of this study.